Welcome to LookChem.com Sign In|Join Free

CAS

  • or

100125-96-0

Ethyl 3-bromo-4-methoxyphenylacetate, a synthetic organic molecule with the molecular formula C11H13BrO3, is a member of the phenylacetate class. It is a derivative of phenylacetic acid, featuring a bromine atom and a methoxy group on the aromatic ring. Ethyl 3-broMo-4-Methoxyphenylacetate is primarily used as an intermediate in the synthesis of pharmaceuticals and serves as a research chemical for studying organic reactions and drug development. It is essential to handle Ethyl 3-bromo-4-methoxyphenylacetate with proper safety measures and under professional guidance.

100125-96-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 100125-96-0 Structure

  • Basic information

    1. Product Name: Ethyl 3-broMo-4-Methoxyphenylacetate
    2. Synonyms: Ethyl 3-broMo-4-Methoxyphenylacetate;Ethyl 2-(3-bromo-4-methoxyphenyl)acetate;3-Bromo-4-methoxybenzeneacetic acid ethyl ester
    3. CAS NO:100125-96-0
    4. Molecular Formula: C11H13BrO3
    5. Molecular Weight: 273.12312
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 100125-96-0.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: Ethyl 3-broMo-4-Methoxyphenylacetate(CAS DataBase Reference)
    10. NIST Chemistry Reference: Ethyl 3-broMo-4-Methoxyphenylacetate(100125-96-0)
    11. EPA Substance Registry System: Ethyl 3-broMo-4-Methoxyphenylacetate(100125-96-0)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 100125-96-0(Hazardous Substances Data)

100125-96-0 Usage

Uses

Used in Pharmaceutical Industry:
Ethyl 3-bromo-4-methoxyphenylacetate is used as a key intermediate in the synthesis of various pharmaceuticals for its unique structural features, including a bromine atom and a methoxy group on the aromatic ring. Its presence in the synthesis process contributes to the development of new drugs with potential therapeutic applications.
Used in Agrochemical Industry:
Ethyl 3-bromo-4-methoxyphenylacetate is also utilized as an intermediate in the production of agrochemicals, such as pesticides and herbicides. Its unique chemical structure allows for the creation of effective compounds that can protect crops and enhance agricultural productivity.
Used in Research and Development:
As a research chemical, Ethyl 3-bromo-4-methoxyphenylacetate is employed in the study of organic reactions and drug development. Its unique properties make it a valuable tool for understanding reaction mechanisms, optimizing synthesis processes, and discovering new compounds with potential applications in various fields.

Check Digit Verification of cas no

The CAS Registry Mumber 100125-96-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,0,1,2 and 5 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 100125-96:
(8*1)+(7*0)+(6*0)+(5*1)+(4*2)+(3*5)+(2*9)+(1*6)=60
60 % 10 = 0
So 100125-96-0 is a valid CAS Registry Number.

100125-96-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name Ethyl (3-bromo-4-methoxyphenyl)acetate

1.2 Other means of identification

Product number -
Other names [3-bromo-4-(methyloxy)phenyl]acetic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:100125-96-0 SDS

100125-96-0Relevant articles and documents

DP2 Antagonist and Uses Thereof

-

Page/Page column 32, (2011/02/26)

Described herein is the DP2 antagonist [2′-(3-benzyl-1-ethyl-ureidomethyl)-6-methoxy-4′-trifluoromethyl-biphenyl-3-yl]-acetic acid, or a pharmaceutically acceptable salt thereof. Also described are methods of preparing the DP2 antagonist, or a

Discovery and optimization of a biphenylacetic acid series of prostaglandin D2 receptor DP2 antagonists with efficacy in a murine model of allergic rhinitis

Scott, Jill M.,Baccei, Christopher,Bain, Gretchen,Broadhead, Alex,Evans, Jilly F.,Fagan, Patrick,Hutchinson, John H.,King, Christopher,Lorrain, Daniel S.,Lee, Catherine,Prasit, Peppi,Prodanovich, Pat,Santini, Angelina,Santini, Brian A.

scheme or table, p. 6608 - 6612 (2011/12/04)

Biphenylacetic acid (5) was identified through a library screen as an inhibitor of the prostaglandin D2 receptor DP2 (CRTH2). Optimization for potency and pharmacokinetic properties led to a series of selective CRTH2 antagonists. Compounds demonstrated potency in a human DP2 binding assay and a human whole blood eosinophil shape change assay, as well as good oral bioavailability in rat and dog, and efficacy in a mouse model of allergic rhinitis following oral dosing.

HETEROALKYL BIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS

-

Page/Page column 91, (2010/04/28)

Described herein are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists of PGD2 receptors, alone and

HETEROARYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS

-

Page/Page column 106-107, (2010/04/27)

Described herein are heteroaryl compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the heteroaryl compounds described. Also described herein are methods of using such antagonists o

ANTAGONISTS OF LYSOPHOSPHATIDIC ACID RECEPTORS

-

Page/Page column 17, (2010/06/22)

Described herein are compounds that are antagonists of lysophosphatidic receptor(s). Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such antagonists, alone and in combination with other compounds, for treating LPA-dependent or LPA-mediated conditions or diseases.

ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS

-

Page/Page column 129, (2009/10/21)

Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions and medicaments that include the antagonists of PGD2 receptors described herein, as well as methods of using such a

N,N-DISUBSTITUTED AMINOALKYLBIPHENYL ANTAGONISTS OF PROSTAGLANDIN D2 RECEPTORS

-

Page/Page column 14, (2009/08/16)

Described herein are compounds that are antagonists of PGD2 receptors. Also described are pharmaceutical compositions that include the compounds described herein, and methods of using such antagonists of PGD2 receptors, alone or in combination with other compounds, for treating respiratory, cardiovascular, and other PGD2-dependent or PGD2-mediated conditions or diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 100125-96-0